Results 41 to 50 of about 605,346 (215)

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr‐mutated lung cancer

Molecular Oncology, EarlyView.
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura, Tadahiro Kuribayashi, Johannes Brägelmann, Sachi Okawa, Masataka Taoka, Shunta Mori, Tomoka Nishimura, Takaaki Tanaka, Go Makimoto, Kiichiro Ninomiya, Kammei Rai, Eiki Ichihara, Ryohei Katayama, Katsuyuki Hotta, Masahiro Tabata, Yosuke Togashi, Yoshinobu Maeda, Martin L. Sos, Katsuyuki Kiura, Kadoaki Ohashi   +19 more
wiley   +1 more source

Cáncer de Cavidad Oral

Medicina, 2004
Todas las conferencias sobre oncología deberían iniciarse diciendo EL CANCER ES CURABLE, a condición que se haga un diagnostico precoz de el. Esto es una realidad para casi todas las neoplasias malignas ya que es bien sabido por todos los oncólogos que ...
Edmond Chediak
doaj  

New insights into oral cancer—Risk factors and prevention: A review of literature

International Journal of Preventive Medicine, 2020
The oral cancer constitutes 48% of head and neck cancer cases. Ninety percent of oral cancer cases are histologically diagnosed as oral squamous cell carcinomas (OSCCs).
Soussan Irani
doaj   +1 more source

Loss of proton‐sensing TDAG8 increases tumor progression in mouse models of colon cancer

Molecular Oncology, EarlyView.
Loss of the pH‐sensing receptor TDAG8 accelerates colorectal cancer progression in mice. Animals lacking TDAG8 expression had increased tumor growth, DNA damage, and recruitment of tumor‐associated immune cells, including macrophages, neutrophils, and monocytes.
Ermanno Malagola, Yasmine Illi, Anna Bircher, Marijn Wilmink, Rachele F. Malagutti, Solenn Ottié, Cordelia Schuler, Pedro A. Ruiz, Cheryl de Vallière, Klaus Seuwen, Gerhard Rogler, Martin Hausmann   +11 more
wiley   +1 more source

Oral cancer awareness amongst hospital nursing staff: a pilot study

BMC Oral Health, 2009
Background Oral cancer is as prevalent as cervical and testicular cancer in the United Kingdom. Nursing staff provide the oral health care for the patient population in hospital.
Johnson Sarah, Kavi Vikram P, Harris Andrew T, Carter Lachlan M, Kanatas Anastasios   +4 more
doaj   +1 more source

Circulating microRNA signatures of cachexia and cancer in Canis familiaris as a comparative oncology model for human disease

Molecular Oncology, EarlyView.
Circulating microRNAs as biomarkers of cachexia and sex‐specific cancer in senior dogs. In 25 client‐owned dogs, four circulating miRNAs (miR‐15a, miR‐15b, miR‐16, miR‐140) were downregulated in cachexia, with miR‐16 the strongest individual biomarker (AUC = 0.899).
Soon‐Seok Park, Kyongman An, Gyeonghwa Kim, Soo‐Nyun Choi, Hong‐Ki Lee, Keun Hur, Kyu‐Shik Jeong   +6 more
wiley   +1 more source

Preoperative circulating tumor cells integrated with imaging analysis for prognostic evaluation in head and neck squamous cell carcinoma

Molecular Oncology, EarlyView.
Detecting circulating tumor cells (CTCs) in blood before surgery may help predict outcomes in patients with head and neck squamous cell carcinoma (HNSCC). Here, we show when combined with tumor size and lymph node involvement from routine imaging, CTC status identifies high‐risk patients with poorer survival—offering a simple, minimally invasive tool ...
Susanne Flach, Gizem Abaci, Tom Huberty, Axel Lechner, Lukas Käsmann, Jens Ricke, Sophia Stöcklein, Martin Canis, Philipp Baumeister, Marianna Alunni‐Fabbroni   +9 more
wiley   +1 more source

Neoadjuvant immunotherapy in resectable head and neck cancer: oral cavity carcinoma as a potential research model. [PDF]

Ther Adv Med Oncol, 2021
Gutiérrez Calderón V, Cantero González A, Gálvez Carvajal L, Aguilar Lizarralde Y, Rueda Domínguez A.   +4 more
europepmc   +1 more source

Prevalencia de tumores benignos y malignos de cavidad oral, Instituto Autónomo Hospital Universitario de Los Andes. 2010 - 2014

Revista GICOS, 2017
Los tumores de cavidad oral incluyen varios subsitios: labio, dos tercios anteriores de la lengua, mucosa bucal, piso de la boca, paladar duro, encías, y trígono retromolar. Suponen 5% de todas las neoplasias en varones y 2% en mujeres.
María Ochoa, Joan Chipia Lobo, Nelsón Ordosgoiti, Edmi Camargo   +3 more
doaj  

Estado nutricional de los pacientes con cáncer de cavidad oral

Nutrición Hospitalaria, 2013
Introducción: El cáncer de cavidad oral ocupa el doceavo lugar a nivel mundial. El tratamiento del cáncer de cavidad oral es habitualmente cirugía seguida de radioterapia, la cual puede estar indicada sola o con quimioterapia; este tipo de terapias ...
Dana Aline Pérez Camargo, Luigina De Nicola Delfín, Silvio A. Ñamendys-Silva, Erika Thalia Copca Mendoza, Margarita Hernández Méndez, Ángel Herrera Gómez, Abelardo Meneses García   +6 more
doaj   +1 more source